Otsuka Holdings Co., Ltd. (OTSKY)

OTCMKTS · Delayed Price · Currency is USD
23.86
+0.12 (0.51%)
Feb 21, 2025, 3:00 PM EST
29.18%
Market Cap 25.85B
Revenue (ttm) 14.82B
Net Income (ttm) 2.18B
Shares Out n/a
EPS (ttm) 4.03
PE Ratio 11.85
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,629
Average Volume 42,335
Open 24.86
Previous Close 23.74
Day's Range 23.53 - 24.86
52-Week Range 19.18 - 32.41
Beta 0.19
RSI 31.75
Earnings Date Feb 14, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr... [Read more]

Sector Healthcare
Founded 1921
Employees 34,388
Stock Exchange OTCMKTS
Ticker Symbol OTSKY
Full Company Profile

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY Financial Statements

News

Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript

Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript

6 days ago - GuruFocus

Otsuka Holdings reports FY results

10 days ago - Seeking Alpha

Otsuka Holdings Co., Ltd. reports Q3 results

Otsuka Holdings Co., Ltd. reported a significant increase in revenue and profit for the nine-month period ended September 30.

4 months ago - Seeking Alpha

Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific

Otsuka Holdings Co. is considering options for its holding in Hong Kong-listed MicroPort Scientific Corp., including selling its stake in the medical device maker, according to people familiar with th...

4 months ago - BNN Bloomberg